CAPZA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.07653902353877E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.37190000973442E-09 |
Normal-vs-Stage2 |
1.76946000000067E-05 |
Normal-vs-Stage3 |
1.90199966887405E-10 |
Normal-vs-Stage4 |
3.25994786720685E-12 |
Stage1-vs-Stage2 |
2.067000E-01 |
Stage1-vs-Stage3 |
9.822300E-03 |
Stage1-vs-Stage4 |
2.012200E-04 |
Stage2-vs-Stage3 |
6.100600E-01 |
Stage2-vs-Stage4 |
2.124600E-01 |
Stage3-vs-Stage4 |
3.913800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.23376872554581E-13 |
Normal-vs-AfricanAmerican |
9.457700E-03 |
Normal-vs-Asian |
1.959910E-04 |
Caucasian-vs-AfricanAmerican |
3.57039999999698E-05 |
Caucasian-vs-Asian |
3.742600E-01 |
AfricanAmerican-vs-Asian |
8.397200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.94029253669714E-12 |
Normal-vs-Female |
4.05219968691028E-10 |
Male-vs-Female |
5.348400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.401400E-03 |
Normal-vs-Age(41-60Yrs) |
7.31559257616254E-12 |
Normal-vs-Age(61-80Yrs) |
1.71660463621492E-11 |
Normal-vs-Age(81-100Yrs) |
5.116500E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.714800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.114800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.921220E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.622400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.624300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.135700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.701940E-02 |
Normal-vs-Grade 2 |
2.20629958747054E-10 |
Normal-vs-Grade 3 |
1.20380372337081E-11 |
Normal-vs-Grade 4 |
1.5771828287825E-12 |
Grade 1-vs-Grade 2 |
1.339230E-01 |
Grade 1-vs-Grade 3 |
3.322200E-01 |
Grade 1-vs-Grade 4 |
1.621170E-03 |
Grade 2-vs-Grade 3 |
5.334600E-01 |
Grade 2-vs-Grade 4 |
7.658200E-03 |
Grade 3-vs-Grade 4 |
1.040420E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.12810000124841E-10 |
Normal-vs-ccB subtype |
1.54121160278464E-12 |
ccA subtype-vs-ccB subtype |
2.666200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.84074977482851E-12 |
Normal-vs-N1 |
9.019400E-04 |
N0-vs-N1 |
8.273600E-02 |
|
|